Other
2031 and thereafter
Guardant Health 2031 and thereafter decreased by 66.9% to $297K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 66.9%, from $897K to $297K.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2024
Last reportedQ1 2026May 7, 2026
Metric ID:
other_finite_lived_intangible_asset_expected_amortizatio_3193b4Historical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $1.66M | $1.66M | $1.66M | $897K | $897K | $897K | $297K |
| QoQ Change | — | +0.0% | +0.0% | -46.0% | +0.0% | +0.0% | -66.9% |
| YoY Change | — | — | — | -46.0% | -46.0% | -46.0% | -66.9% |
Range$297K – $1.66M
CAGR-68.3%
Avg YoY Growth-51.2%
Median YoY Growth-46.0%
Frequently Asked Questions
- What is Guardant Health's 2031 and thereafter?
- Guardant Health (GH) reported 2031 and thereafter of $297K in Q1 2026.
- How has Guardant Health's 2031 and thereafter changed year-over-year?
- Guardant Health's 2031 and thereafter decreased by 66.9% year-over-year, from $897K to $297K.